Perfluorooctane sulfonate increased hepatic expression of OAPT2 and MRP2 in rats
- 3 November 2010
- journal article
- research article
- Published by Springer Nature in Archives of Toxicology
- Vol. 85 (6) , 613-621
Abstract
The toxicity of perfluorooctane sulfonate (PFOS), a persistent organic compound, is of great concern. Several studies have reported that PFOS decreases circulating thyroid hormone (TH) concentrations. However, the mechanisms involved remain to be determined. Female rats were exposed to (1) vehicle; (2) PFOS (0.2, 1.0, and 3.0 mg/kg); (3) propylthiouracil (PTU, 10 mg/kg); or (4) PTU (10 mg/kg) + PFOS (3.0 mg/kg) by gavage once a day for 5 consecutive days. Parameters including contents of total T4 (TT4) and total T3 (TT3) in both serum and bile, serum concentrations of transthyretin and thyroglobulin, as well as transcripts of transporters involved in hepatic uptake and efflux of T4 were determined in control and PFOS-exposed groups. TT4 and TT3 were also analyzed in PTU and PTU + PFOS groups in order to reflect the different hormone effects between PFOS, PTU, and PFOS + PTU. Results showed that serum TT4 and TT3 decreased, while bile TT4 and TT3 remained stable following PFOS exposure. Exposure to 3.0 mg/kg of PFOS significantly enhanced hepatic organic anion transporter OATP2 mRNA expression (1.43 times of control). Treatment with PFOS increased hepatic expression of multidrug resistance–associated protein MRP2, approximately 1.80 and 1.69 times of control in 1.0 and 3.0 mg/kg groups, respectively. Spearman’s correlation coefficients revealed that MRP2 mRNA expression correlated well with serum TT4 level (r = −0.528, P = 0.012). Serum thyroglobulin and transthyretin levels remained stable. Serum TT3, bile TT4, and bile TT3 were significantly different between PFOS and PTU groups. No significant differences of TT4 and TT3 in both serum and bile were observed between PTU and PTU + PFOS (P > 0.05). In conclusion, PFOS increased hepatic expression of OAPT2, which could possibly enhance hepatic uptake and metabolism of T4 in rats. PFOS-induced TT4 deficiency is mainly due to the extrathyroidal metabolism of T4, which is probably different from the classic goitrogen, PTU.Keywords
This publication has 37 references indexed in Scilit:
- Gestational and lactational exposure to potassium perfluorooctanesulfonate (K+PFOS) in rats: Toxicokinetics, thyroid hormone status, and related gene expressionReproductive Toxicology, 2009
- Perfluorinated compounds – Exposure assessment for the general population in western countriesInternational Journal of Hygiene and Environmental Health, 2009
- Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS)Toxicology, 2008
- The Applicability of Biomonitoring Data for Perfluorooctanesulfonate to the Environmental Public Health ContinuumEnvironmental Health Perspectives, 2006
- Environmental chemicals and thyroid functionEuropean Journal of Endocrinology, 2006
- In Vitro Profiling of the Endocrine-Disrupting Potency of Brominated Flame RetardantsToxicological Sciences, 2006
- Ecotoxicological Evaluation of Perfluorooctanesulfonate (PFOS)2006
- Pre-validation study for OECD enhanced test guideline 407 protocol by gavage for 4 weeks using propylthiouracil and tamoxifenToxicology Letters, 2003
- Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulin.Environmental Health Perspectives, 1999
- Molecular Characterization and Tissue Distribution of a New Organic Anion Transporter Subtype (oatp3) That Transports Thyroid Hormones and Taurocholate and Comparison with oatp2Journal of Biological Chemistry, 1998